The CDC specifically recommended that expectant mothers 32 to 36 weeks into their pregnancy receive the shot, Pfizer's ...
The U.S. Centers for Disease Control and Prevention have recommended the first-ever vaccine designed to protect infants from ...
An independent panel of independent advisers for the Centers for Disease Control and Prevention backed Pfizer's respiratory ...
The FDA approved the first vaccine for pregnant women to prevent RSV in infants. The vaccine would allow babies to be born ...
The federal Food and Drug Administration approved the Pfizer Covid-19 vaccine for emergency use in children ages 5 to 11 this morning, opening the door for vaccinations to begin. Before that can ...
The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...
The Food and Drug Administration authorized the emergency use of its Pfizer-BioNTech vaccine for adolescents age 12 to 15 today, according to the New York Times. Authorization is given for the ...
RSV is the leading cause of hospitalization for U.S. infants. The new vaccine, Pfizer's bivalent RSVpreF vaccine (trade name Abrysvo), has been shown to reduce the risk of RSV hospitalization for ...
The latest COVID-19 boosters could be approved and on their way to health systems this week. The question: Will people go and ...
US regulators approved updated versions of the COVID-19 vaccines made by Pfizer Inc. and Moderna Inc. Monday as ...
An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory syncytial virus, or RSV, be given during pregnancy, providing an extra ...
